Differences in NSAID tolerability profiles. Fact or fiction?

doi:10.2165/00002018-199410030-00001

Review

. 1994 Mar;10(3):183-95.

doi: 10.2165/00002018-199410030-00001.

Differences in NSAID tolerability profiles. Fact or fiction?

K J Skeith¹, M Wright, P Davis

Affiliations

PMID: 8043221
DOI: 10.2165/00002018-199410030-00001

Review

Differences in NSAID tolerability profiles. Fact or fiction?

K J Skeith et al. Drug Saf. 1994 Mar.

. 1994 Mar;10(3):183-95.

doi: 10.2165/00002018-199410030-00001.

Authors

K J Skeith¹, M Wright, P Davis

Affiliation

¹ Department of Medicine, University of Alberta, Edmonton, Canada.

PMID: 8043221
DOI: 10.2165/00002018-199410030-00001

No abstract available

PubMed Disclaimer

Cited by

Nonsteroidal anti-inflammatory drugs and heart failure.
Bleumink GS, Feenstra J, Sturkenboom MC, Stricker BH. Bleumink GS, et al. Drugs. 2003;63(6):525-34. doi: 10.2165/00003495-200363060-00001. Drugs. 2003. PMID: 12656651 Review.
Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
Nurmohamed MT, van Halm VP, Dijkmans BA. Nurmohamed MT, et al. Drugs. 2002;62(11):1599-609. doi: 10.2165/00003495-200262110-00003. Drugs. 2002. PMID: 12109923 Review.
Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR, Balfour JA. Lee CR, et al. Drugs. 1994 Dec;48(6):907-29. doi: 10.2165/00003495-199448060-00007. Drugs. 1994. PMID: 7533698 Review.
Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.
Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P. Jouzeau JY, et al. Drugs. 1997 Apr;53(4):563-82. doi: 10.2165/00003495-199753040-00003. Drugs. 1997. PMID: 9098660 Review.
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
Gillis JC, Brogden RN. Gillis JC, et al. Drugs. 1997 Jan;53(1):139-88. doi: 10.2165/00003495-199753010-00012. Drugs. 1997. PMID: 9010653 Review.

See all "Cited by" articles

References

1. J Clin Pharmacol. 1992 Apr;32(4):317-23 - PubMed
1. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):916-25 - PubMed
1. Br Med J. 1954 Apr 3;1(4865):795 - PubMed
1. J Clin Pharmacol. 1984 May-Jun;24(5-6):240-6 - PubMed
1. N Engl J Med. 1992 Sep 10;327(11):749-54 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information

[1] J Clin Pharmacol. 1992 Apr;32(4):317-23 - PubMed

[2] J Clin Pharmacol. 1992 Apr;32(4):317-23 - PubMed

[3] Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):916-25 - PubMed

[4] Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):916-25 - PubMed

[5] Br Med J. 1954 Apr 3;1(4865):795 - PubMed

[6] Br Med J. 1954 Apr 3;1(4865):795 - PubMed

[7] J Clin Pharmacol. 1984 May-Jun;24(5-6):240-6 - PubMed

[8] J Clin Pharmacol. 1984 May-Jun;24(5-6):240-6 - PubMed

[9] N Engl J Med. 1992 Sep 10;327(11):749-54 - PubMed

[10] N Engl J Med. 1992 Sep 10;327(11):749-54 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Differences in NSAID tolerability profiles. Fact or fiction?

Affiliation

Differences in NSAID tolerability profiles. Fact or fiction?

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical